Background: The direct factor Xa (FXa) inhibitors Apixaban and Rivaroxaban are used for stroke prevention in patients with atrial fibrillation (AF). The FXa-inhibitors do not require routine laboratory monitoring…
reproducible reverse phase high performance liquid chromatographic method was developed for the determination of Rivaroxaban in pure drug and pharmaceutical dosage form. The quantification was carried out using enable…
Rivaroxaban is a Direct Oral Anticoagulant (DOAC), which has six licensed indications, including the use for prevention of stroke and systemic embolism with non-valvular Atrial Fibrillation ... treatment of Venous…
Conclusion: This study demonstrates the systematic development of a discriminatory dissolution method for Rivaroxaban, a BCS Class 2 drug exhibiting pH-independent solubility. The dissolution method presented here…
Objective: Clinical trials are evaluating the use of rivaroxaban in patients with end-stage renal disease (ESRD), including those taking phosphate binders. The purpose of this in vitro dissolution study ... assess the…
This study was designed to evaluate the pharmacokinetics of a new generic formulation of rivaroxaban compared with a brand in healthy Iranian volunteers. Twenty-eight healthy volunteers enrolled in this ... hours after…
Background: Rivaroxaban, an oral thing Xa inhibitor, is effective in treating venous thromboembolism, and has been shown to save you thromboembolic activities in atrial fibrillation. Low dose rivaroxaban prevents venous…
Novel anticoagulants such as rivaroxaban, a direct factor Xa inhibitor, have presented advancement in management of venous thromboembolism and atrial fibrillation. The most common complication of rivaroxaban treatment…
Background: We present 4 cases of alveolar hemorrhage in patients receiving rivaroxaban. While bleeding is a common complication of rivaroxaban therapy reported by multiple case reports in the literature, this…
strokes. The purpose of this analysis was to determine the efficacy of rivaroxaban, a commonly prescribed Factor Xa inhibitor, compared to the use of warfarin, the current mainstay of treatment ... include non-valvular…
Purpose: To evaluate the bioequivalence of two strengths of Rivaroxaban 10 mg and 20 mg film-coated tablets manufactured by PT Dexa Medica with the reference drug, Xarelto® film-coated ... strength study was completed…
Background: Rivaroxaban used to treat the coagulation is prescribed for covid 19 and post covid 19 (viral pneumonia and LRTI). To study the role of rivaroxaban in subjects with covid ... post covid 19 and assess the…
warfarin, low molecular weight heparin like enoxaparin, Fondaparinux sodium, direct factor Xa inhibitor like rivaroxaban and apixaban, and mechanical thromboprophylaxis. METHODS We studied the efficacy of oral…
crushed products are available only for BCS Class I and Class III drugs. Since rivaroxaban is a Class II drug which can be administered crushed and mixed with fluids ... label, randomized, single dose, two-period…
assess how rivaroxaban affects coagulation function, inflammatory factors and endothelial function in individuals who have received percutaneous coronary intervention for coronary heart disease sheds light on its…
Various platforms of laboratory assay are available for measuring the drug level of dabigatran, rivaroxaban and apixaban. The measurement of rivaroxaban and apixaban can be done by anti-Xa assay ... from Werfen Company…
chromatographic technique is created for the separation and simultaneous assay of two antiplatelet drugs, Rivaroxaban (RIV) with Clopidogrel (CLP). The developed and validated method is characterized by its simplicity…
Oral Anticoagulants (OAC) is recommended for stroke prevention. Rivaroxaban is a new generation oral anticoagulant. Depression and anxiety are psychiatric disorders which frequently coexist with the Coronary Artery…
precise, accurate and reproducible RP-HPLC method for simultaneous estimation of Clopidogrel and Rivaroxaban. The separation was carried by Kromasil C18 column (250 × 4.6 mm, 5μ) with UV detection ... linear over the…
Four sensitive and selective stability indicating methods for the determination of rivaroxaban (RIV) were developed. Method a was an isocratic RP-HPLC, good resolution between peaks corresponding to the degradates…
Four sensitive and selective stability indicating methods for the determination of rivaroxaban (RIV) in the presence of its alkaline degradates (A,B) and in its pharmaceutical formulation were developed. Method…
single-center, retrospective cohort study of 98 cases of DOAC therapy (apixaban, dabigatran, or rivaroxaban) in a Veteran population with AF aged > 75 years. Baseline characteristics and comorbidities were collected…
speed, high resolution Reverse phase-HPLC method was developed for estimation of assay in Rivaroxaban drug substance. The separation of drug from the possible impurities was achieved in an Inertsil ... conditions. Using…
Rivaroxaban is one of most common used DOACs in the treatment of VTE. Rivaroxaban has been tested in a series of premarketing studies and after it has been used ... interventional studies and in real life studies. All…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.